openPR Logo
Press release

What's driving the Blood Plasma Product Market Trends? | Key Players are: CSL, Grifols, Shire, Octapharma, Biotest AG, Sanquin, LFB

07-19-2019 05:41 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

What's driving the Blood Plasma Product Market Trends? | Key

Blood plasma product is the extracted portion from the blood using fractionation process to deliver products rich in plasma proteins. These products are used as body fluids, antibodies and clotting factors in medical industries that aid in treatment of chronic ailments like auto-immune disorders and haemophilia. The global blood plasma product market is expected to witness a significant growth during the forecast period due to the high demand by a large pool of patients with no alternative therapeutic approach. Blood plasma product have a wide range of components that have clinical use such as, Albumin, Factor VIII, Factor IX, immunoglobulin, fibrinogen with their major applications in bleeding disorders (haemophilia, immunological disorders), massive hemorrhage and in traumatic injuries. Moreover, the presence of biomarkers in plasma adds to their application in clinical diagnosis of diseases. These factors will drive the growth of global blood plasma product market in future.

Download free report sample at: https://www.psmarketresearch.com/market-analysis/blood-plasma-product-market/report-sample

According to a report by World Federation of Haemophilia, there are 304,362 people suffering from bleeding disorders such as, haemophilia, von Willebrand disease and others. The statistics depict 5.6% increase in prevalence of diseases from 2014-2015. The present therapeutics involve a continuous supply of plasma product as supplement. This increase in prevalence of bleeding disorders will drive a positive impact on the growth of the market during the forecast period 2017-2023. Moreover, government and private organization support blood donation programs to meet the rising demand of plasma, which will further drive the market growth. The growth of geriatric population results in the increase in prevalence of age related diseases such as, kidney disorder that requires blood plasma product as a therapeutic. These factors will drive the growth of the global blood plasma product market.

Browse full report at: https://www.psmarketresearch.com/market-analysis/blood-plasma-product-market

The identification of new proteins in blood plasma to be used as therapeutic products are under clinical investigation. This will provide opportunity to companies to maximize the volume of blood plasma fractionation. Further, exploring novel therapeutic application of the known blood plasma product to be used for other diseases will also provide ample opportunities to the market players to invest and expand in the global market.

Geographically, North America held the largest share in the global blood plasma product market in 2016, followed by Europe. North America was the prominent market for the blood plasma collection, fractionation and product formation. Asia Pacific global blood plasma product market is expected to witness the fastest growth during the forecast period (2017-2023). The growing geriatric population and the increase in prevalence of blood disorder diseases are the factors responsible for the growth.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=blood-plasma-product-market

The key players in the global blood plasma product market are:
1- CSL
2- Grifols
3- Shire
4- Octapharma
5- Biotest AG
6- Sanquin
7- LFB

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Blood Plasma Product Market Trends? | Key Players are: CSL, Grifols, Shire, Octapharma, Biotest AG, Sanquin, LFB here

News-ID: 1808004 • Views: 407

More Releases from P&S Intelligence

Respiratory Diagnostic and Monitoring Device Market Comprehensive Review of its …
The respiratory diagnostic and monitoring device market valued $4,348.1 million in 2015, and it is further predicted to progress at an 8.1% CAGR during the forecast period (2016–2022). Details of Report: http://bit.ly/31Hc1yt The growth of the market is attributed to the increasing geriatric population, prevalence of respiratory disease and smoking, pollution level, healthcare expenditure, and rapid urbanization. Respiratory diagnostic and monitoring devices provide monitoring and diagnostic evaluation of cardiopulmonary system disorders and
Respiratory Care Device Market Outlook - Top Companies, Trends and Future Prospe …
The respiratory care device market is witnessing growth due to the increasing prevalence of respiratory diseases and smoking, growing geriatric population, rising pollution, rapid urbanization, and surging incidence of premature births. It garnered a revenue of over $15.0 billion in 2015, and it is projected to advance at a 9.5% CAGR during the forecast period (2016–2022) and generate $28.2 billion revenue, ultimately. The diagnostic evaluation, management, control, therapy, and monitoring
Prefilled Syringes Market Supply Demand Analysis in Europe by Top Key Player For …
The global prefilled syringes market accounted for $4.7 billion revenue in 2017 and is projected to witness tremendous growth at a CAGR of 8.3% during the forecast period (2018–2023). The factors driving the growth of the market are expanding biopharmaceutical industry, increasing demand for injectable pharmaceutical products, advancements in technology, and upgraded combination therapy applications. A prefilled syringe is a single-dose, disposable syringe, containing parental drugs filled by manufacturers. Request
Artificial Intelligence in Cyber Security Market Industry Outlook, Market Dynami …
The growth drivers for the artificial intelligence in cyber security market are the rising adoption of bring-your-own-device (BYOD) policy and surging threat of malicious attacks and cyber frauds. A revenue of $1.2 billion was generated by the market in 2016, and it is projected to grow at a 36.0% CAGR during the forecast period 2017–2023. Request to get the report sample pages at : www.psmarketresearch.com/market-analysis/artificial-intelligence-in-cyber-security-market/report-sample The adoption of chatbots to reduce

All 5 Releases


More Releases for Blood

Blood Donation Chair
Blood Donation Chair Size: 190 L * 92 W * 135 - 164 H cm Back plate, the angle of inclination of the leg plate. Height adjustment. The adjustments are all electrically controlled and easy to operate. This product comes with three LINAK motors Maximum load capacity: 240 kg Optional: CPR function, weighing function The marketplace was wholly developed by the Jiangsu Medwish Network Technology Co., Ltd., a private corporation based in Jiangsu,
Blood Group Typing Market Banks on Increasing Need for Blood, Blood Products, an …
The global blood group typing market is foreseen to garner a massive demand in the foreseeable future owing to certain factors such as the rising demand for blood and blood products. Nonetheless, the market growth could see an escalation on the back of other factors such as increasing prenatal testing which requires blood grouping, mounting count of road mishaps and trauma incidences requiring blood transfusion, and increasing application in forensic
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New
Blood Group Typing Market Banks on Increasing Need for Blood, Blood Products, an …
The global blood group typing market is foreseen to garner a massive demand in the foreseeable future owing to certain factors such as the rising demand for blood and blood products. Nonetheless, the market growth could see an escalation on the back of other factors such as increasing prenatal testing which requires blood grouping, mounting count of road mishaps and trauma incidences requiring blood transfusion, and increasing application in forensic
Blood Bank Market 2017
ReportsWeb.com has announced the addition of the “Global Blood Bank Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Blood Bank industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard